-transparent.png){kind=logo}
The effect of N-(6-aminohexyl)-5-chloro-naphthalene-1-sulfomide (W-7) and trifluoperazine (TFP) was examined on ACTH release from cultured rat anterior pituitary cells and pituitary halves. These drugs significantly inhibited the ACTH release induced by synthetic ovine corticotropin-releasing factor (CRF) in a dose-related manner. In pituitary halves, arginine vasopressin (AVP) at 10 and 100 ng/ml showed almost the same ACTH-releasing activity as CRF at the same concentrations. W-7 and TFP inhibited the CRF-and AVP-induced ACTH release from pituitary halves. The cyclic AMP levels in the pituitary halves were significantly increased by CRF, but not AVP. Although W-7 inhibited CRF-induced ACTH release, it did not have an effect in cyclic AMP accumulation. These results suggest that CRF exerts ACTH-releasing activity through both the calcium-calmodulin system and cyclic AMP system and that AVP stimulates ACTH release mainly through the calcium-calmodulin system.
K Murakami, and
K Hashimoto, and
Z Ota
October 1978,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Murakami, and
K Hashimoto, and
Z Ota
April 1982,
Biochemical and biophysical research communications,
K Murakami, and
K Hashimoto, and
Z Ota
November 1982,
Endocrinology,
K Murakami, and
K Hashimoto, and
Z Ota
January 1979,
Hormone research,
K Murakami, and
K Hashimoto, and
Z Ota
April 1995,
The Journal of biological chemistry,
K Murakami, and
K Hashimoto, and
Z Ota
June 1998,
The American journal of physiology,
K Murakami, and
K Hashimoto, and
Z Ota
January 1994,
Nihon Naibunpi Gakkai zasshi,
K Murakami, and
K Hashimoto, and
Z Ota
January 1981,
Peptides,
K Murakami, and
K Hashimoto, and
Z Ota
August 1994,
Clinical and investigative medicine. Medecine clinique et experimentale,
K Murakami, and
K Hashimoto, and
Z Ota
March 1974,
Nature,
